Wednesday, February 3, 2016

A Bill Gates-backed startup that wants to edit your genes just raised nearly $100 million

A Bill Gates-backed startup that wants to edit your genes just raised nearly $100 million

Editas has become the first company to price an initial public offering (IPO) in the US in 2016.
The gene-editing company raised $94.4 million and priced 5.9 million shares at $16 per share, according to Reuters.
Editas Medicine, a startup based in Cambridge, Massachusetts, that is working on potential uses for the gene-editing tool CRISPR-Cas9, plans to trade under the ticker EDIT, according todocuments filed last month.
The offering follows a period of inactivity. January was the firstIPO-free month since September 2011, according to Dealogic. The first IPO wouldn't usually come this late, but market volatility has seen companies hold off from going public.
CRISPR-Cas9 is a technology that allows scientists to swap a particular, potentially faulty gene with another, potentially healthy one. So far, the technology hasn't been used in people — except in nonviable human embryos — but Editas is aiming for a 2017 clinical trial.
The company plans to use the IPO proceeds to fund the clinical trials and preclinical studies, and to expand its technology. Editas said that it also expects opportunities to expand through the acquisition of other companies, products, or technologies and could use some of the funds for those deals.
Editas was founded in part by Jennifer Doudna and Feng Zhang, two of the first developers of the CRISPR technology. In August, it raised $120 million from investors, including Bill Gates, to fund research.
Editas has said in the past that it plans to start its research on a rare eye disorder called Leber congenital amaurosis (LCA). The condition mainly affects the retina, a layer at the back of the eyeball that picks up light and sends that information to the brain, where it's translated into images.
Starting at infancy, people with LCA have a hard time seeing anything other than large, bright shapes.
Editas declined to comment.
More: CRISPR Editas IPO Health

Chipotle's horrible quarter was just as bad as they thought

Chipotle's horrible quarter was just as bad as they thought

chipotle guac serving scoopingJoe Raedle/Getty
Chipotle reported its third-quarter earnings results on Tuesday, its first since the E. coli outbreak linked to it.
The restaurant chain confirmed that its quarterly sales were negative for the first time since it went public about a decade ago.
Same-store sales, at locations open for at least one year, fell 14.6%, in line with its warning last month.
Chipotle reported adjusted earnings per share of $2.17 ($1.81 expected according to Bloomberg), and revenues of $999.7 million ($1.01 billion forecast).
In the earnings release, Chipotle co-CEO Steve Ells said the fourth quarter was "the most challenging period in Chipotle’s history."
Co-CEO Monty Moran added that 2016 will be "a very difficult year", even as the company anticipates a pickup in the number of customers.
The release also disclosed that Chipotle was served a subpoena on January 28 that broadens the scope of a prior one from the US Attorney's office for the District of California, amid a criminal investigation. It requires the company to produce information related a norovirus outbreak in a Simi Valley, California restaurant in August.
The big E. coli outbreak linked to Chipotle, first reported in October, sickened 55 people across 11 states. Also, 120 Boston College students showed norovirus symptoms after they ate at the restaurant during the quarter.
On Monday, the Centers for Disease Control and Prevention (CDC) said the E. coli outbreaksappeared to be over
But the damage is done, and it's ugly. Since news of the first outbreak crossed on October 31, the stock has fallen about 25%.
In after-hours trading, the stock rose by as much as 3% before dropping by the same magnitude.
Screen Shot 2016 02 02 at 2.57.49 PMGoogleChipotle shares since news of the E. coli scare first broke.

Yahoo hangs the 'for sale' sign

Yahoo hangs the 'for sale' sign

Yahoo CEO Marissa MayerREUTERS/Ruben SprichYahoo CEO Marissa Mayer.
Yahoo just officially hung up a "for sale" sign.
Company chairman Maynard Webb writes that Yahoo is "exploring additional strategic alternatives" to the four-point growth plan the company laid out in a press release.
The company's stock is down nearly 2% after-hours, despite its fourth-quarter earnings revenue beat.
Here's Webb (emphasis added):
The Board also believes that exploring additional strategic alternatives, in parallel to the execution of the management plan, is in the best interest of our shareholders. Separating our Alibaba stake from our operating business continues to be a primary focus, and our most direct path to value maximization. In addition to continuing work on the reverse spin, which we've discussed previously, we will engage on qualified strategic proposals."
This announcement follows Wall Street rumblings about how Yahoo should sell its core internet business. The company's stock is down nearly 40% from its 52-week high.
More: Yahoo Earnings

ChemChina just made the biggest foreign purchase in Chinese history

ChemChina just made the biggest foreign purchase in Chinese history

Ren Jianxin Chairman ChemChina SyngentaREUTERS/Arnd WiegmannRen Jianxin (L) Chairman of China National Chemical Corp arrives at the headquarters of Swiss agrochemicals maker Syngenta in Basel, Switzerland February 3, 2016.
BASEL, Switzerland (Reuters) - China made its boldest overseas takeover move yet when state-owned ChemChina agreed a $43 billion bid for Swiss seeds and pesticides group Syngenta on Wednesday.
The largest ever foreign purchase by a Chinese firm, announced by both companies, will accelerate a shake-up in global agrochemicals and marks a setback for U.S. firm Monsanto, which failed to buySyngenta last year.
China is looking for ways to secure security of food supply for its population and theSyngenta deal will give it access to technology and expertise as well as global market share and Western distribution networks.
"Only around 10 percent of Chinese farmland is efficient. This is more than just a company buying another. This is a government attempting to address a real problem," a source close to the deal told Reuters.
With growth slowing at home, Chinese companies are looking abroad for deals that can boost their businesses. If completed, theSyngenta acquisition would be more than double CNOOC's $17.7 billion purchase of Canadian energy company Nexen in 2012.
Syngenta shares rose on news of the deal, but at around 412 Swiss francs, were some way below the agreed offer price of $465 per share, equivalent to 480 francs, reflecting market concerns that the deal could yet stumble over regulatory hurdles.
However, Syngenta CEO John Ramsay , who described the deal as "very appropriate and attractive", said he saw no major barriers and noted that ChemChina had secure financing in place.
A source with knowledge of the deal said the funding would come from a range of Chinese players, as well as HSBC and China CITIC Bank International.
"I think the overall regulatory approvals will not be very challenging," Ramsay told Reuters, adding he expected antitrust regulators to acknowledge the limited overlap.
The Committee on Foreign Investment in the United States (CFIUS), whose mandate is U.S. national security, would not pose a major hurdle, Ramsay said.
Syngenta's board would still have to consider any rival offers, Ramsay said. But ChemChina, short for China National Chemical Corp., has agreed to pay about $3 billion in fees should it fail to meet all requirements for the deal, while Syngenta will owe ChemChina about $1.5 billion if the deal falls through for any reasons the Swiss group is accountable for.
"The discussions between our two companies have been friendly, constructive and cooperative, and we are delighted that this collaboration has led to the agreement," ChemChina Chairman Ren Jianxin said.
In a hint of what may be in store for the enlarged group, Syngenta's chairman said ChemChina will be on the lookout for more deals as China strives to improve its food supply.
"ChemChina has a very ambitious vision of the industry in the future. Obviously it is very interested in securing food supply for 1.5 billion people and as a result knows that only technology can get them there," Michel Demare said.
China ChemChina WomanREUTERSA woman checks her phone at the headquarters of China National Chemical Corporation in Beijing, July 20, 2009.

China calling

ChemChina's move on Syngenta may be the biggest, but it is not the first as Chinese corporates shift offshore.
Similar deals include last year's buyout of Italian tire maker Pirelli by ChemChina. In January, ChemChina announced the acquisition of German industrial machinery maker KraussMaffei Group for about $1 billion.
Beijing is keen to boost farming productivity as it seeks to cut reliance on food imports amid limited farm land, a growing population and higher meat consumption.
A global glut of corn and soybeans has depressed grain prices for the past three years, prompting U.S. farmers to reduce spending on everything from equipment to seeds and pesticides. The cutbacks, along with pressure from investors and a desire to bolster profit, have sent many of the world's largest agricultural companies scrambling to cut deals.
DuPont and Dow Chemical Co agreed in December to combine in an all-stock merger valued at $130 billion in a first step toward breaking up into three separate businesses, a move that was seen as a trigger for further consolidation.
The ChemChina offer will allow for dividend payments to Syngenta shareholders of up to 16 Swiss francs per share, including a special dividend of 5 francs on closing.
(Additional reporting by Michael Shields, Freya Berry, Lisa Jucca, Lawrence White, Elzio Barreto and Aizhu Chen; Writing by Alexander Smith; Editing by Ian Geoghegan and xxx)
Read the original article on Reuters. Copyright 2016. Follow Reuters on Twitter.

Tuesday, February 2, 2016

KFC wins China payout over mutant chicken rumours

KFC wins China payout over mutant chicken rumours

[SHANGHAI] A Shanghai court has fined three local tech firms for helping spread rumours about Yum Brands Inc's KFC fast food chain that included doctored photos of deformed chickens and allegations the birds had six wings and eight legs.
In a statement on its official microblog, the Xuhui District People's Court said Yingchenanzhi Success and Culture Communication, Taiyuan Zero Point Technology and Shanxi Weilukuang Technology had "damaged KFC's reputation" and "caused it economic losses" by permitting the allegations to be posted on their social messaging accounts.
The companies were ordered to make an official apology and fined a combined 600,000 yuan (S$130,000), an amount that fell far short of the 1.5 million yuan Yum had asked each company to pay in damages.
"We brought suit against these individuals for making false statements about the quality of our food and we are pleased with the outcome," China-based Yum spokeswoman Cindy Wei said in emailed comments sent to Reuters.
Reuters was unable to find contact numbers or websites for the three companies fined by the court.
Yum is battling to turn around its fortunes in China, its largest market, where its sales have taken a serious hit after a series of food safety scares since the end of 2012. The firm is planning to spin off its China unit by the end of this year.
KFC China brought the suit against the firms in June last year for using ten accounts on Tencent Holdings Ltd's popular messaging platform WeChat to spread the defamatory posts.
Food safety is a major concern in China, with frequent scandals ranging from recycled "gutter oil" and years-old"zombie meat", to dairy laced with industrial chemicals.
A food scandal in 2014 that dented Yum and rival McDonald's Corp came to a close earlier this week when a Chinese court fined US food supplier OSI Group and handed jail terms to ten of its executives over allegations it had reused returned food products to avoid losses.
REUTER
S

Two biotechnology companies end US IPO lull

Two biotechnology companies end US IPO lull

[NEW YORK] Biotechnology companies BeiGene Ltd and Editas Medicine Inc priced the first initial public offerings of 2016 in the United States on Tuesday, following a bout of stock market volatility that shut the IPO market for over a month.
In the absence of any new stock market jitters, the pricing of the two offerings could embolden other companies to proceed with their IPOs. Some are in need to raise cash after the freeze in the IPO market weighed on their ability to fund their growth.
Many IPO investors got burnt in 2015 after the stock market rout decimated their gains. Investors who bought shares in IPOs since the start of 2015, and held on to them, are now staring at a negative 18.5 per cent return, according to investment advisory firm Rennaissance Capital.
BeiGene, a Beijing-based company which develops molecules and monoclonal antibodies to treat cancer, priced 6.6 million shares at US$24, the top of its previous US$22 to US$24 range, raising US$158.4 million. This was upsized, due to strong investor demand, from an original offering of 5.5 million shares.
Editas, a Cambridge, Massachusetts-based company that aims to treat diseases through gene editing, priced 5.9 million shares at US$16, the bottom of its previously indicated range of US$16 to US$18, raising US$94.4 million.
Both IPO's had support from some of these companies'existing shareholders that committed to snap up shares in the offerings. Two of BeiGene's investors, hedge funds Baker Brothers Inc and Hillhouse Capital Group, had indicated their intention to buy half the company's offering.
Also helping Editas is its connection to big-name investors. Boris Nikolic, who previously served as chief adviser for science and technology to Microsoft Corp founder Bill Gates, sits on the board of Editas. "(For companies to succeed with their IPOs, they need to be) a solid business, that aren't going to be impacted so much by this global slowdown that people fear," Kathleen Smith, Renaissance Capital principal, said in an interview.
Two bigger IPOs are scheduled to price next week. Waste collection company ADS Waste Holdings Inc is looking to raise up to US$471 million, while airport restaurant concessionaire OTG Experience Inc is hoping to raise as much as US$585 million.
REUTERS

Gold resilient as this year's best commodity as stocks, oil wilt

Gold resilient as this year's best commodity as stocks, oil wilt

[SINGAPORE] Gold held its ground near a three-month high as losses in global equities and oil fanned haven demand, bolstering its position as this year's best performing commodity as investors reduced expectations of further US rates rises.
Bullion for immediate delivery traded at US$1,127.66 an ounce at 9:38 am Singapore from US$1,129.01 on Tuesday, when it rose to US$1,131.08, the highest level since Nov 3, according to Bloomberg generic pricing.
The metal has outperformed all other members of the Bloomberg Commodity Index this year, surging 6.3 per cent, as global stocks sank 7.9 per cent.
The "market situation suggests that gold is one of the beneficiaries of the market gyrations," Bob Takai, chief executive officer and president of Sumitomo Corporation Global Research Co, said by phone.
"I'm not sure if the Fed will really continue to raise interest rates for the rest of the year," he said, citing recent US growth data.
BLOOMBERG

Malaysia state leader Mukhriz Mahathir quits post amid PM scandals

Malaysia state leader Mukhriz Mahathir quits post amid PM scandals

[KUALA LUMPUR] A leading Malaysian politician relinquished his post as a state chief minister on Wednesday in what is widely seen as the latest move by scandal-plagued Prime Minister Najib Razak to purge potential rivals.
Ruling party politician Mukhriz Mahathir, son of former longtime premier Mahathir Mohamad, resigned as head of Kedah state following an internal party push to oust him, Malaysian media reported.
Mr Mukhriz had been mentioned among potential future contenders for prime minister but his fortunes have flagged due to his outspoken father's ongoing campaign to oust Mr Najib over sensational corruption allegations.
Malaysia has been seized for more than a year by reports that huge sums of money were diverted from a state-owned investment company closely linked to Mr Najib.
The affair escalated last July when it was revealed that Mr Najib had received payments of US$681 million to his personal bank accounts.
Both Mr Najib and the investment company, 1Malaysia Development Berhad (1MDB), strongly deny that the US$681 million involved 1MDB money.
Mr Mukhriz, 51, is the latest top figure in the long-ruling United Malays National Organisation (UMNO) to suffer in the fallout.
After the Najib payment was revealed, he reshuffled his cabinet to sack several members including his deputy prime minister, who had called for transparency, and the attorney-general, who was heading investigations.
A new Najib-appointed attorney-general last week declared the premier clear of any wrongdoing, claiming the payment was a legal "personal donation" from the Saudi royal family.
That story is widely disbelieved in Malaysia, and the move to exonerate Mr Najib has sparked accusations of a conspiracy to subvert justice to protect Mr Najib.
Authorities in Switzerland, Singapore, the United States and Hong Kong also are looking into money flows related to 1MDB.
AFP

US says Southeast Asian summit 'not anti-China'

US says Southeast Asian summit 'not anti-China'

[WASHINGTON] A summit with Southeast Asian leaders that President Barack Obama is hosting later this month is "not anti-China," a State Department official said Tuesday.
The meeting will bring leaders from the 10-nation Association of Southeast Asian Nations (ASEAN) at the Californian resort of Sunnylands on February 15-16.
"This summit is not about China. It's about the US and ASEAN," US Assistant Secretary of State for East Asia Daniel Russel said in an interview with the AP, Reuters and AFP news agencies.
"This is not about China, this is not anti-China." The US administration has focused on bolstering ASEAN as a counterpoint to Chinese regional power.
"This is the culmination of a seven-plus-year investment the United States has made first and foremost in the Asia pacific region, but also in ASEAN in particular," Mr Russel said.
"I think it demonstrates that the rebalance has reached cruising altitude," he added, referring to the Obama administration's focus on its "pivot" toward Asia since 2009.
Several ASEAN states are embroiled in an increasingly bitter spat with China over disputed territory in the South China Sea.
The US says it takes no position on ownership of the various reefs and islets under dispute, but insists freedom of navigation in the vital shipping lane must be maintained.
"This set of challenges in Southeast Asia, particularly the disputes over land features and maritime entitlement in South China Sea isn't a zero-sum game, this is not a proxy war between China and the United States," Mr Russel said.
"This is a direct challenge to the question of whether the countries in the region and the claimants in the South China Sea, and particularly China... would be guided by the universal principles and the rule of law."
He insisted that Asia was "not certainly a battleground for big powers' competition."
AF
P

728 X 90

336 x 280

300 X 250

320 X 100

300 X600